Symposium on Cardiovascular Regenerative Medicine
Agenda
Tuesday October 4
7:00 a.m. |
Registration |
8:00 a.m. |
Welcome and Opening Remarks
Manfred Boehm, M.D.
National Heart, Lung, and Blood Institute
Keynote Address
Susan B. Shurin, M.D.
Acting Director
National Heart, Lung, and Blood Institute
NIH Center for Regenerative Medicine and Stem Cell Therapies
Mahendra S. Rao, M.D., Ph.D.
Director
NIH Center for Regenerative Medicine
Questions and Answers |
9:00 - 10:25 a.m. |
Session I: New Advances in IPS-cell Technology
Moderator: Sean M. Wu, M.D., Ph.D.
Massachusetts General Hospital and Harvard Medical School
A Chemical Approach to Controlling Cell Fate
Sheng Ding, Ph.D. Gladstone Institute of Cardiovascular Disease
Insights Into the Mechanisms Underlying iPSC Generation
Kathrin Plath, Ph.D. University of California, Los Angeles, School of Medicine
Modified mRNA: A Powerful New Tool for Cardiovascular Research
Derrick J. Rossi, Ph.D. Harvard Medical School
|
|
Questions and Answers |
10:25 a.m. |
Break |
10:55 a.m. - 12:30 p.m. |
Session II: Reprogramming for Cardiovascular Regeneration
Moderator: Joseph C. Wu, M.D., Ph.D.
Stanford School of Medicine
Epigenetic Regulation of Cardiac Regeneration
W. Robb MacLellan, M.D. University of California, Los Angeles, School of Medicine
Reprogramming Approaches for Cardiovascular Disease
Deepak Srivastava, M.D. Gladstone Institute of Cardiovascular Disease and University of California, San Francisco
Cardiogenesis from Pluripotent Human Stem Cells: Mechanisms and Applications
Charles E. Murry, Ph.D., M.D. University of Washington |
|
Questions and Answers |
12:30 p.m. |
Lunch |
1:30 - 3:25 p.m. |
Session III: Stem Cells and in vitro Disease Modeling
Moderator: Deepak Srivastava, M.D.
Gladstone Institute of Cardiovascular Disease and University of California,
San Francisco
Capturing Disease Genomes in iPS Cells
George Q. Daley, M.D., Ph.D. Children's Hospital Boston and Harvard Medical School
Pursuing Pluripotency
Ihor R. Lemischka, Ph.D. Mount Sinai School of Medicine
Modeling Inherited Cardiogenic Disorders With Human Induced Pluripotent Stem Cells
Lior Gepstein, M.D., Ph.D. Rappaport Institute (Israel)
miRNAs and Cellular Reprogramming
Edward E. Morrisey, Ph.D. University of Pennsylvania School of Medicine
|
|
Questions and Answers |
3:25 p.m. |
Adjourn |
3:30 - 5:00 p.m. |
Poster Session |
6:30 p.m. |
Networking Dinner at Tragara Ristorante (register and pay separately) |
View Wednesday October 5 Agenda
Last Updated August 19, 2011
|